ACE’s Imaging Products
ACE’s NIR-I and NIR-II/SWIR imaging agents outperform all current benchmarks.
ACE’s Product Portfolio
ACE develops ultra-sensitive multimodal imaging agents designed to advance early cancer detection and precision oncology.
Product
Modality
Status
NIR-I CPNs
Photoacoustic
Validated – surpasses commercial benchmark
NIR-II (SWIR) CPNs
Deep-tissue imaging
Completed
CP-LP NPs
Dual-mode imaging
At preclinical stage
Antibody-Targeted NPs
Precision oncology
Ongoing